MC1R Chromosome 16
Melanocortin 1 receptor
Upload your DNA to see your personal genotypes for variants in MC1R.
What This Gene Does
This intronless gene encodes the receptor protein for melanocyte-stimulating hormone (MSH). The encoded protein, a seven pass transmembrane G protein coupled receptor, controls melanogenesis. Two types of melanin exist: red pheomelanin and black eumelanin. Gene mutations that lead to a loss in function are associated with increased pheomelanin production, which leads to lighter skin and hair color. Eumelanin is photoprotective but pheomelanin may contribute to UV-induced skin damage by generating free radicals upon UV radiation. Binding of MSH to its receptor activates the receptor and stimulates eumelanin synthesis. This receptor is a major determining factor in sun sensitivity and is a genetic risk factor for melanoma and non-melanoma skin cancer. Over 30 variant alleles have been identified which correlate with skin and hair color, providing evidence that this gene is an important component in determining normal human pigment variation. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
Melanocortin receptors
Locus Type
gene with protein product
Location
16q24.3
Ensembl
ENSG00000258839
Associated Conditions (19)
Melanoma
cutaneous malignant
susceptibility to
5
SKIN/HAIR/EYE PIGMENTATION
VARIATION IN
2
Tyrosinase-positive oculocutaneous albinism
Increased analgesia from kappa-opioid receptor agonist
female-specific
Skin/hair/eye pigmentation 2
red hair/fair skin
ALBINISM
OCULOCUTANEOUS
TYPE II
MODIFIER OF
MC1R-related disorder
Skin and Hair Hypopigmentation
UV-induced skin damage
Key Variants
RS1110400
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS11547464
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS12102534
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS1260091224
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS1374244663
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS1805006
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS1805007
Conflicting classifications of pathogenicity
Skin/hair/eye pigmentation 2, red hair/fair skin, Increased analgesia from kappa-opioid receptor agonist
Health Risk
RS200000734
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS201171524
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS201326893
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS201489928
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
RS201533137
Conflicting classifications of pathogenicity
Melanoma, cutaneous malignant, susceptibility to
Health Risk
All Variants (42)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS1110400 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS11547464 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS12102534 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS1260091224 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS1374244663 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS1805006 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS1805007 | Health Risk | Conflicting classifications of pathogenicity | Skin/hair/eye pigmentation 2, red hair/fair skin, Increased analgesia from kappa-opioid receptor agonist |
| RS200000734 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS201171524 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS201326893 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS201489928 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS201533137 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS201632257 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS2045699975 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS33932559 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS34474212 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS367985661 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS368507952 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS369016553 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS370472871 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS371618933 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS372152373 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS373344683 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS373703770 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS376670171 | Health Risk | Conflicting classifications of pathogenicity | Tyrosinase-positive oculocutaneous albinism, Melanoma, cutaneous malignant |
| RS546618600 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS553516665 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS554831935 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS564161331 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS745994833 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS750618617 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS754971328 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS760458744 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS763647934 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS765848904 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS773260532 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS773395822 | Health Risk | Conflicting classifications of pathogenicity | Melanoma, cutaneous malignant, susceptibility to |
| RS1805009 | Health Risk | Conflicting classifications of pathogenicity; risk factor | Skin/hair/eye pigmentation 2, red hair/fair skin, Tyrosinase-positive oculocutaneous albinism |
| RS143395134 | Health Risk | Likely pathogenic | Tyrosinase-positive oculocutaneous albinism, Skin and Hair Hypopigmentation, Tyrosinase-positive oculocutaneous albinism |
| RS2045705764 | Health Risk | Pathogenic/Likely pathogenic | SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 |
| RS104894523 | Health Risk | risk factor | UV-induced skin damage, susceptibility to, UV-induced skin damage |
| RS1310082996 | Health Risk | risk factor | UV-induced skin damage, susceptibility to, UV-induced skin damage |